First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast – Stratipath

First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast

August 5, 2025

The web publication ”First world health tech” picked up Stratipath’s press release about the Stratipath Breast biopsy capability.

MORE NEWS:

Stratipath Breast Achieves CE Marking Under IVDR, Reinforcing Its leading position in AI-Based Breast Cancer Precision Diagnostics

Stratipath Breast Validated in TAILORx Presented at ASCO 2026

Helsinki University Hospital adopts Stratipath Breast for AI-based risk profiling in Breast Cancer Care

Stratipath and PathAI Partner to Expand Access to AI-based Precision Diagnostics

Press releases:

Stratipath Breast Achieves CE Marking Under IVDR, Reinforcing Its leading position in AI-Based Breast Cancer Precision Diagnostics

Stratipath Breast Validated in TAILORx Presented at ASCO 2026

Helsinki University Hospital adopts Stratipath Breast for AI-based risk profiling in Breast Cancer Care

Stratipath and PathAI Partner to Expand Access to AI-based Precision Diagnostics

IN THE MEDIA:

First world health tech: Press Release Stratipath releases biopsy capability for its CE-IVD marked AI diagnostic solution, Stratipath Breast

ESMO daily: AI integration in breast cancer – a long way ahead?

Stratipath team contributes to foundation model research published in Nature

Pharma Times: Diagnexia and Stratipath link up brings AI breast cancer diagnostics to UK